Traditional Chinese medicines in the management of cardiovascular diseases:A comprehensive systematic review [PDF]
, 2016 AIMS: The aim was to perform a systematic review of the efficacy of traditional Chinese medicines (TCM) in cardiovascular disease. METHODS: Electronic databases were searched up to 11 November 2015 for all randomized‐controlled trials evaluating the ...
Ferro, Albert, Layne, Kerry
core +4 more sources
Efficacy and Safety of MLC601 (NeuroAiD®), a Traditional Chinese Medicine, in Poststroke Recovery: A Systematic Review [PDF]
Cerebrovascular Diseases, 2013 <b><i>Background:</i></b> Subsequent to a pooled analysis of 2 trials, several more studies have been published assessing the benefit of MLC601 in stroke patients. Hence, it is timely to conduct an updated meta-analysis to frame the interpretation of the results of an ongoing large multicenter, randomized, double-blind, placebo ...
Fahad Javaid, Siddiqui +3 more
openaire +2 more sources
Vascular dementia: neurological assessment and cardiovascular manifestations [PDF]
, 2023 Vascular dementia is a form of dementia caused by brain damage resulting from problems with blood flow to the brain. It is often associated with risk factors and cardiovascular manifestations, such as high blood pressure, diabetes mellitus, ischemic ...
Binsfeld, Willimar Gleiser Schmidt +11 more
core +2 more sources
Stroke Research and Treatment, Volume 2020, Issue 1, 2020., 2020 Background. Improving our knowledge about the impact of restorative therapies employed in the rehabilitation of a stroke patient may help guide practitioners in prescribing treatment regimen that may lead to better post‐stroke recovery and quality of life. Aims.
Manuel Murie-Fernández +2 more
wiley +1 more source
Herbs and Rehabilitation after Stroke Study: A Multi-center, Double-blinded, Randomized Trial in Hong Kong [PDF]
, 2016 published_or_final_versio
Chang, CM +17 more
core +1 more source
Targeting neurogenesis: a promising therapeutic strategy for post-stroke treatment with Chinese herbal medicine [PDF]
, 2014 published_or_final_versio
Chen, X, Chen, X, Deng, R, Shen, J
core +1 more source
Frequency and Clinical Impact of Serious Adverse Events on Post-Stroke Recovery with NeuroAiD (MLC601) versus Placebo: The CHInese Medicine Neuroaid Efficacy on Stroke Recovery Study [PDF]
Cerebrovascular Diseases, 2020 <b><i>Background:</i></b> Most comparative clinical trials are designed to assess the treatment effect for efficacy endpoints, with less emphasis on the analysis of safety outcomes. However, an extensive analysis of safety data could demonstrate beneficial results in terms of effectiveness by reducing serious adverse events ...
Narayanaswamy, Venketasubramanian +3 more
openaire +2 more sources
CHInese medicine NeuroAiD efficacy on stroke recovery - Extension study (CHIMES-E): A multicenter study of long-term efficacy [PDF]
, 2015 © 2015 S. Karger AG, Basel. Background: The CHInese Medicine NeuroAiD Efficacy on Stroke recovery (CHIMES) study was an international randomized double-blind placebo-controlled trial of MLC601 (NeuroAiD) in subjects with cerebral infarction of ...
Alejandro C. Baroque II +22 more
core +1 more source
Organizational factors determining access to reperfusion therapies in Ischemic Stroke-Systematic literature review [PDF]
, 2022 Background: After onset of acute ischemic stroke (AIS), there is a limited time window for delivering acute reperfusion therapies (ART) aiming to restore normal brain circulation. Despite its unequivocal benefits, the proportion of AIS patients receiving
Botelho, Ana +4 more
core +2 more sources
Evidence-Based Complementary and Alternative Medicine, Volume 2015, Issue 1, 2015., 2015 Evidence‐based medicine (EBM), by integrating individual clinical expertise with the best available clinical evidence from systematic research, has in recent years been established as the standard of modern medical practice for greater treatment efficacy and safety.
Foon Yin Fung +2 more
wiley +1 more source